Your browser doesn't support javascript.
loading
Risperidone on apomorphine-induced stereotyped behavior and auditory sensory gating in rhesus monkeys.
Iwamura, Yoshihiro; Nakako, Tomokazu; Matsumoto, Atsushi; Ogi, Yuji; Yamaguchi, Masataka; Kobayashi, Atsushi; Matsumoto, Kenji; Katsura, Yasunori; Ikeda, Kazuhito.
Afiliación
  • Iwamura Y; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Nakako T; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Matsumoto A; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Ogi Y; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Yamaguchi M; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Kobayashi A; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Matsumoto K; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Katsura Y; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan.
  • Ikeda K; Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Osaka, Japan. Electronic address: kazuhito-ikeda@ds-pharma.co.jp.
Behav Brain Res ; 428: 113883, 2022 06 25.
Article en En | MEDLINE | ID: mdl-35398232
ABSTRACT
The ameliorating effect of risperidone on apomorphine-induced stereotyped behavior and inhibition of auditory sensory gating was investigated using rhesus monkeys. The total duration of the stereotyped behavior observed in the control group was 43.7 ± 23.0 s (n = 3) between 10 and 25 min after vehicle administration, whereas the duration in the apomorphine-treated (0.1 or 0.15 mg/kg i.m., n = 3) group was observed to be significantly prolonged to 413.0 ± 150.6 s. Administration of 0.01, 0.03, 0.1 mg/kg of risperidone 60 min before apomorphine, significantly reduced the duration of this apomorphine-induced stereotyped behavior to 327 ± 104.9 s (n = 3), 8.3 ± 4.2 s (n = 3), and 0.0 ± × 0.0 s (n = 3, t-test p < 0.05), respectively. Next, the auditory sensory gating test/conditioning (T/C) ratio was used as a bio-marker. The T/C ratio was 0.598 ± 0.0802 in the vehicle-administered control group (n = 4) and was significantly increased to 2.098 ± 0.254 (n = 4) by apomorphine (0.15 mg/kg, i.m.). Administering of risperidone (0.1 mg/kg, s.c.) 30 min before apomorphine treatment significantly restricted the T/C ratio to 0.571 ± 0.0886 (n = 4), compared to the T/C ratio in the vehicle-administered control group. The above results demonstrate, not only behaviorally but also electrophysiologically, the ameliorating effect of risperidone on the induction of schizophrenia-like symptoms by apomorphine in non-human primates.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducta Estereotipada / Apomorfina Límite: Animals Idioma: En Revista: Behav Brain Res Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducta Estereotipada / Apomorfina Límite: Animals Idioma: En Revista: Behav Brain Res Año: 2022 Tipo del documento: Article País de afiliación: Japón
...